[Estimation of the level of endogenous intoxication in septic infants]

Insights

Endogenous intoxication (EI) in septic infants can be assessed using circulating immune complexes (CIC) and leukocyte intoxication index (LII). High levels of CIC and LII post-treatment indicate incomplete recovery and risk of complications in sepsis.

Area of Science:

  • Pediatrics
  • Immunology
  • Critical Care Medicine

Context:

  • Sepsis is a life-threatening condition in infants, often leading to systemic complications.
  • Endogenous intoxication (EI) is a significant factor in sepsis severity and outcomes.
  • Assessing EI requires reliable biomarkers for accurate diagnosis and prognosis.

Purpose:

  • To estimate the degree of endogenous intoxication (EI) in septic infants.
  • To evaluate the utility of circulating immune complexes (CIC) and leukocyte intoxication index (LII) as biomarkers for EI.
  • To correlate EI levels with clinical severity and treatment outcomes in pediatric sepsis.

Summary:

  • A clinical trial involving 46 septic infants (1 month to 1.5 years) assessed EI using CIC and LII levels.
  • Three grades of EI were identified, correlating with clinical conditions.
  • Persistent high CIC and LII levels in 18% of patients post-clinical resolution indicated incomplete recovery and potential for complications.

Impact:

  • High CIC and LII levels serve as indicators of incomplete pathological processes in septic infants.
  • These biomarkers can aid in predicting sepsis progression and recurrence.
  • The findings support the integration of CIC and LII monitoring into routine pediatric sepsis management for improved patient outcomes.